m+Medelevator.RU
← Поиск публикаций
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2025

Long-term considerations following living liver donation-Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety.

СтатьяConsensus StatementНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Rammohan Ashwin, Shankar Sadhana, Syn Nicholas, Mathew Johns Shaji, Bhangui Prashant, Sayed Blayne Amir, Jung Dong-Hwan, Watt Kymberly D, Pomfret Elizabeth A, Roberts John P, Selzner Markus, Chan Albert, Maluf Daniel, Zhu Zhi-Jun, Eghtesad Bijan, Minnee Robert C, Chaudhary Abhideep, Eguchi Susumu, James Paul, Goldaracena Nicolas, Kodali Sudha, Kim Jongman, Man Nancy Kwan, Liapakis Ann Marie, Fipps David C, Taner Timucin, Wiggins Chantal, Ascher Nancy, Mas Valeria R, Chen Chao-Long, Terrault Norah A, Burra Patrizia, Vyas Mary Pressley, Suk-Suh Kyung, Hirschfield Gideon, Broering Dieter, Lerut Jan P, Heimbach Julie, Olthoff Kim M, Selzner Nazia, Rela Mohamed

Аннотация

Living liver donation is a critical component for addressing organ shortage and improving outcomes for patients with end-stage liver disease. As the prevalence of living donor liver transplantation (LDLT) increases worldwide, understanding and optimizing long-term donor health is paramount. The 2025 International Liver Transplantation Society and International Living Donor Liver Transplantation Society (ILTS-iLDLT) Consensus Conference convened experts in the field of liver transplantation to establish evidence-based guidelines focused on the long-term medical, psychological, and social considerations following living liver donation. The aim of this working group was to integrate current evidence and expert consensus on donor follow-up protocols, risk assessment, and management strategies to promote long-term donor health, quality of life, and living liver donor programs globally to safeguard the welfare of this unique population.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты